Ironwood pharmaceuticals inc.官网
WebGet the latest Ironwood Pharmaceuticals, Inc. (IRWD) real-time quote, historical performance, charts, and other financial information to help you make more informed … WebJan 5, 1998 · 天眼查为您提供Ironwood Pharmaceuticals公司概况：Ironwood Pharmaceuticals, Inc. 是一家生物制药公司，主营治疗慢性疾病的药物，如用于肠易激综合症治疗的药物。。查公司，查老板，查关系就上天眼查。
Ironwood pharmaceuticals inc.官网
Did you know?
WebApr 14, 2024 · In other Ironwood Pharmaceuticals news, CEO Thomas A. Mccourt sold 46,129 shares of Ironwood Pharmaceuticals stock in a transaction dated Monday, March 27th. The shares were sold at an average ... WebApr 10, 2024 · See how Ironwood Pharmaceuticals compares to its main competitors: Hoffmann-LA Roche Inc has the most employees (101,200). Employees at AstraZeneca earn more than most of the competitors, with an average yearly salary of $112,988.
WebApr 10, 2024 · Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS … WebDec 16, 2024 · IRONWOOD PHARMACEUTICALS, INC. : News, information and stories for IRONWOOD PHARMACEUTICALS, INC. Nasdaq: IRWD Nasdaq
WebIRONWOOD PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $11.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a … WebJan 4, 2024 · Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and …
WebIronwood Pharmaceuticals Inc是一家胃肠（GI）保健公司，专注于胃肠道产品在未满足需求领域的开发和商业化，包括伴有便秘的肠易激综合征（IBS-C）和慢性特发性便秘（CIC） …
WebNov 4, 2024 · IND for CNP-104 Accepted by FDA; Clinical Trials Planned for the End of 2024 Ironwood to Make a Payment of approximately $20 Million in Upfront and Near-Term Milestones and up to $475 Million in Long-Term Commercial and Regulatory Milestones and Royalties to COUR Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused … lithium penny stocks to watchWeb1 day ago · Ironwood Pharmaceuticals Reports Second Quarter 2024 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand. BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its second quarter 2024 results and recent business performance. lithium perchlorate molar massWebJan 9, 2024 · Jan. 9, 2024, 02:15 PM. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares are trading lower by 10.00% to $11.30 Monday afternoon after the company cut its FY22 sales guidance below analyst ... lithium perchlorate safetyWebMar 16, 2024 · After extensive research and analysis, Zippia's data science team found that: Ironwood Pharmaceuticals has 219 employees. 44% of Ironwood Pharmaceuticals employees are women, while 56% are men. The most common ethnicity at Ironwood Pharmaceuticals is White (66%). 13% of Ironwood Pharmaceuticals employees are … lithium penny stocks to buyWebJul 22, 2024 · BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 5, 2024. Individuals interested in participating in the call should dial (833) 350-1432 (U.S. and Canada) or (647) 689-6932 … lithium pentane 1 thiolatelithium perchlorate casWebSeeing gaps in intercity connections? Call Indian Trails customer service at (800) 292-3831 if you need help buying a ticket to your final destination. imr of nauru